Tenax Therapeutics, Inc(NASDAQ:TENX) 
Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company develops levosimendan, which completed a phase II clinical trials for the treatment of...
Website: http://www.tenaxthera.com
Founded: 1967
Full Time Employees: 9
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 6.07
H 6.25
L 5.67
C 5.80
V 24,650
10EMA 5.80
20EMA 5.80
60EMA 5.80
120EMA 5.80
250EMA 5.80